Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01621646 · ClinicalTrials.gov registry record · NA
The Effect of Daily Consumption of Eggs on Cognitive Function in the Elderly
A NA study, sponsored by Tufts University.
- Completed
- Registry status
- NA
- Development phase
- 44
- Enrollment target
NCT01621646 is a NA study that has completed, run by Tufts University. The registered enrollment target is 44 participants.
The verdict
NCT01621646, a NA study, has completed, sponsored by Tufts University.
- COMPLETED
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
Study Summary
Cognitive impairment is also a major risk factor for development of dementia later in life. Findings from our studies suggest that the carotenoids, lutein and zeaxanthin may be important in cognitive function in the elderly. The investigators have previously reported eggs to be a highly bioavailable source of lutein and zeaxanthin. Our study evaluates long-term egg intervention as a treatment strategy for age-related cognitive impairment which could possibly prevent the onset of dementia. The investigators have also shown that lutein supplementation significantly improved verbal fluency scores in healthy older women. Our studies have shown that egg interventions can significantly increase serum lutein concentrations in older adults. Based on the sum of our findings, the next logical step will be to investigate the ability of lutein and zeaxanthin contained in eggs to influence cognitive function in older adults. The investigators hypothesize that there will be a significant increase in cognitive function measures in older adults provided with meals containing 2 egg/day at the end of 6 months, while no significant improvements will be observed in older adults given daily meals containing egg substitute. The proposed study is designed as a randomized, placebo controlled trial that tests the effects of 6 month supplementation with 2 eggs/day on cognitive function in older adults. Secondary analyses will determine whether baseline MP density predicts relative effectiveness of the intervention on cognitive function. Secondary outcomes include plasma biomarkers of oxidative stress and inflammation.
Interventions
- OTHER eggs or egg whites
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2012-07 |
| Est. Completion | 2015-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01621646
The ClinicalTrials.gov registry entry for NCT01621646 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tufts University, which has 163 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which eggs or egg whites is the first listed.
NCT01621646 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01621646 about?
NCT01621646 is a clinical study titled "The Effect of Daily Consumption of Eggs on Cognitive Function in the Elderly". Cognitive impairment is also a major risk factor for development of dementia later in life. Findings from our studies suggest that the carotenoids, lutein and zeaxanthin may be important in cognitive function in the elderly. The investigators have previously reported eggs to be a highly bioavailable...
What is the current status of trial NCT01621646?
This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2012-07. Estimated completion is 2015-08.
What interventions are being tested in trial NCT01621646?
The interventions under investigation include: eggs or egg whites (OTHER).
Who is sponsoring clinical trial NCT01621646?
This trial is sponsored by Tufts University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.